Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
GROWTH HORMONE-RELEASING HORMONE PEPTIDES AND FORMULATIONS THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/014978
Kind Code:
A3
Abstract:
Described herein are sermorelin peptide compositions formulated for high oral bioavailability and high rates of absorption for treatment in a variety of applications, such as treatment of low testosterone, diminished endurance and energy, deficient immune system, slow metabolism, deficient cognitive function, poor sleep health, and poor bone health.

Inventors:
GLENN RUSSELL (US)
HAI JUSTIN (US)
Application Number:
PCT/US2022/039585
Publication Date:
May 19, 2023
Filing Date:
August 05, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
REBALANCE HEALTH INC (US)
International Classes:
A61K38/25; A61K47/18; A61K47/12; A61P5/02
Foreign References:
US20100203014A12010-08-12
US20110077281A12011-03-31
US20080038335A12008-02-14
US10265343B22019-04-23
US20040171534A12004-09-02
Other References:
CARLES CANTO; RIEKELTH. HOUTKOOPER; EIJA PIRINEN; DOUY. YOUN; MAAIKEH. OOSTERVEER; YANA CEN; PABLOJ. FERNANDEZ-MARCOS; HIROYASU YA: "The NADPrecursor Nicotinamide Riboside Enhances Oxidative Metabolism and Protects against High-Fat Diet-Induced Obesity", CELL METABOLISM, CELL PRESS, UNITED STATES, vol. 15, no. 6, 25 April 2012 (2012-04-25), United States , pages 838 - 847, XP028520518, ISSN: 1550-4131, DOI: 10.1016/j.cmet.2012.04.022
Attorney, Agent or Firm:
UMPIERRE, Alicia (US)
Download PDF: